Choose Your Cannabis Method
Semaglutide (Ozempic, Wegovy, Rybelsus) — All Methods🍬 Edibles — 2–4+ hours
Semaglutide + Edibles
Gummies, Chocolates, Capsules, Baked Goods
⚠️ Caution
⚠️ Caution
🌿 Smoking — 1–10 minutes
Semaglutide + Smoking
Flower, Pre-Rolls, Joints, Pipes
🔵 Moderate
🔵 Moderate
💨 Vaping — 1–10 minutes
Semaglutide + Vaping
Cartridges, Disposable Vapes, Dry Herb Vaporizers
🔵 Moderate
🔵 Moderate
💧 Tinctures — Sublingual component unchanged; swallowed portion delayed 2–4+ hours
Semaglutide + Tinctures
Sublingual Drops Held Under the Tongue
🔵 Moderate
🔵 Moderate
🫙 CBD Oil — Oral: delayed 2–4+ hours on GLP-1; sublingual component less affected
Semaglutide + CBD Oil
Oral CBD Drops, Softgels, High-CBD Tinctures
🔵 Moderate
🔵 Moderate
About Semaglutide: The GLP-1 Gastric Slowing Effect
Why Method MattersSemaglutide produces significant gastric emptying delay — one of the strongest gastric slowing effects in the GLP-1 class. This applies to all three brand forms. Rybelsus (oral semaglutide) adds a second oral-GI variable: it must be taken fasting with only 4 oz of water at least 30 minutes before food. Oral cannabis products taken near the Rybelsus dosing window create direct absorption timing conflicts.
| Method | Affected by GLP-1? | Onset on Semaglutide | Primary Risk |
|---|---|---|---|
| Edibles | Yes — significantly delayed | 2–4+ hours | ⚠️ Caution |
| Smoking | No — lung absorption | 1–10 min (unchanged) | 🔵 Moderate |
| Vaping | No — lung absorption | 1–10 min (unchanged) | 🔵 Moderate |
| Tinctures | Partial — depends on technique | Mixed (15 min–4+ hours) | 🔵 Moderate |
| CBD Oil | Yes — oral absorption delayed | 2–4+ hours | 🔵 Moderate |
Check Your Full Medication List
Taking Semaglutide plus other medications? Use InteractSafe to review your complete combination.
Semaglutide + Cannabis Full Profile →Or open the full interaction checker · Free · No account required
Other GLP-1 Medications
Compare by DrugGLP-1 Guide
Tirzepatide (Mounjaro)
GIP/GLP-1 dual receptor agonist
GLP-1 Guide
Orforglipron (Foundayo)
Oral GLP-1 receptor agonist (small molecule)
GLP-1 Guide
Dulaglutide (Trulicity)
GLP-1 receptor agonist
GLP-1 Guide
Liraglutide (Victoza)
GLP-1 receptor agonist
GLP-1 Guide
Exenatide (Byetta)
GLP-1 receptor agonist
GLP-1 Guide
Retatrutide (No brand name assigned (Phase 3 clinical trials as of June 2026))
GLP-1/GIP/Glucagon triple receptor agonist (investigational)